| 2024/06/28 22:30:00 | |
|---|---|
| Price | |
| 6.97 USD | |
| Difference | 1.45% (0.10) |
General attributes
| ISIN | BE0974358906 |
| Symbol | NYXH |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 224 EUR |
| Benchmark | BEL 20 INDEX |
Market data
| Bid (Bid size) | 2.81 USD (200) |
| Ask (Ask size) | 7.15 USD (100) |
| Open | 7.15 USD |
| High | 7.15 USD |
| Low | 6.93 USD |
| Close (prev. day) | 6.8701 USD |
| VWAP | 7.029995 USD |
| Volume (pcs) | 5,167 |
| Trading volume | 36,304.77 |
| Number of trades | 80 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: NYXOAH SA NPV |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/06/28 22:30:00 | |
|---|---|
| Price | |
| 6.97 USD | |
| Difference | 1.45% (0.10) |
General attributes
| ISIN | BE0974358906 |
| Symbol | NYXH |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Other |
| Security type | Stock |
| Market cap (m) | 224 EUR |
| Benchmark | BEL 20 INDEX |
Market data
| Bid (Bid size) | 2.81 USD (200) |
| Ask (Ask size) | 7.15 USD (100) |
| Open | 7.15 USD |
| High | 7.15 USD |
| Low | 6.93 USD |
| Close (prev. day) | 6.8701 USD |
| VWAP | 7.029995 USD |
| Volume (pcs) | 5,167 |
| Trading volume | 36,304.77 |
| Number of trades | 80 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +48.61% | - | -74.19% |
| Perf (abs.) | +2.28 | - | -20.03 |
| Beta | 1.65 | 0.76 | 0.59 |
| Volatility | 139.49 | 104.57 | 77.72 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 7.32 USD (27,966) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 8.62 USD (48,929) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 11.41 USD (46,633) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 8.60 USD (29,296) |
| YTD High | date | 20.00 USD (2024/03/18) |
| YTD Low | date | 4.00 USD (2024/01/17) |
| 52 Weeks High | date | 20.00 USD (2024/03/18) |
| 52 Weeks Low | date | 4.00 USD (2024/01/17) |
All listings for NYXOAH SA NPV
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Stuttgart | 2024/06/28 | 16:29 | 6.44 EUR | 0.00 | 4 |
| Nasdaq | 2024/06/28 | 22:30 | 6.97 USD | 0.04 | 80 |
| Munich | 2024/06/28 | 08:03 | 6.88 EUR | 0.00 | 2 |
| Frankfurt | 2024/06/28 | 15:29 | 6.20 EUR | 0.00 | 5 |
| Euronext Brussels | 2024/06/28 | 17:37 | 6.50 EUR | 0.15 | 126 |
| Duesseldorf | 2024/06/28 | 08:12 | 6.24 EUR | 0.00 | 3 |
Company Logo
Contact Details
| NYXOAH SA |
| - - |
| Rue Edouard Belin 12 - 1435 Mont-Saint-Guibert |
| Telefon: +32-10-22-23-55 |
| Fax: + |
| E-mail: info@nyxoah.com |
PDF Downloads
| Company report: NYXOAH SA NPV | |
Company Profile
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium. |
Members of Management Board
| Olivier Taelman | Chairman of Managing Board |
| An Moonen | Member of Executive Committee |
| Bruno Onkelinx | Member of Executive Committee |
| Chris Eigenmann | Member of Executive Committee |
| David DeMartino | Member of Executive Committee |
| Loic Moreau | Member of Executive Committee |
Board of directors
| Robert Taub | Chairman of Supervisory Board |
| Jürgen Hambrecht | Member of Supervisory Board |
| Pierre Gianello | Member of Supervisory Board |
| Daniel Wildman | Member of Supervisory Board |
| Kevin Rakin | Member of Supervisory Board |
| Rita Johnson-Mills | Member of Supervisory Board |
| Virginia Kirby | Member of Supervisory Board |